Academic literature on the topic 'Clinical factors'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Clinical factors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Clinical factors"

1

BS, Lakshmi. "Abruptio Placentae – Risk Factors and Clinical Manifestations." Journal of Medical Science And clinical Research 05, no. 01 (January 18, 2017): 15722–27. http://dx.doi.org/10.18535/jmscr/v5i1.82.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Köhne, Claus-Henning, Udo Vanhoefer, and Gernot Hartung. "Clinical predictive factors." European Journal of Cancer 45 (September 2009): 43–49. http://dx.doi.org/10.1016/s0959-8049(09)70015-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jain, Mayank. "Myocardial Infarction in “Women”: Clinical Profile and Risk Factors." Journal of Cardiovascular Medicine and Surgery 4, no. 3 (2018): 221–24. http://dx.doi.org/10.21088/jcms.2454.7123.4318.5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

S, Kannan, and Gowri S. "Motivating factors for recruitment of children in clinical trials." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 04, no. 3 (September 15, 2014): 313–15. http://dx.doi.org/10.58739/jcbs/v04i3.6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ingegnoli, Francesca, Roberto Castelli, and Roberta Gualtierotti. "Rheumatoid Factors: Clinical Applications." Disease Markers 35 (2013): 727–34. http://dx.doi.org/10.1155/2013/726598.

Full text
Abstract:
Rheumatoid factors are antibodies directed against the Fc region of immunoglobulin G. First detected in patients with rheumatoid arthritis 70 years ago, they can also be found in patients with other autoimmune and nonautoimmune conditions, as well as in healthy subjects. Rheumatoid factors form part of the workup for the differential diagnosis of arthropathies. In clinical practice, it is recommended to measure anti-cyclic citrullinated peptide antibodies and rheumatoid factors together because anti-cyclic citrullinated peptide antibodies alone are only moderately sensitive, and the combination of the two markers improves diagnostic accuracy, especially in the case of early rheumatoid arthritis. Furthermore, different rheumatoid factor isotypes alone or in combination can be helpful when managing rheumatoid arthritis patients, from the time of diagnosis until deciding on the choice of therapeutic strategy.
APA, Harvard, Vancouver, ISO, and other styles
6

Heath, David A. "Primary Hyperparathyroidism: Clinicai Presentation and Factors Influencing Clinical Management." Endocrinology and Metabolism Clinics of North America 18, no. 3 (September 1989): 631–46. http://dx.doi.org/10.1016/s0889-8529(18)30357-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nuray Sever, Özlem, Gökmen Aktaş, Başar Aksoy, and Mustafa Yıldırım. "CLINICAL FACTORS PREDICTING RESPONSE TO REGORAFENIB IN METASTATIC COLORECTAL CANCER." Euroasia Journal of Mathematics, Engineering, Natural & Medical Sciences 9, no. 20 (March 25, 2022): 23–27. http://dx.doi.org/10.38065/euroasiaorg.924.

Full text
Abstract:
Colorectal cancer (CRC) is a common disease with high mortality. Regorafenib (Stivarga ®) is an oral small molecule, multiple kinase inhibitor approved worldwide for use in metastatic colorectal cancer. In our study, clinical factors predicting response to regorafenib were investigated. Patients who applied to Gaziantep Medical Park Hospital and Sanko University Medical Faculty Hospital Medical Oncology outpatient clinic between 2010-2021 with the diagnosis of mCRC and using regorafenib were included in the study. Electronic medical records of the patients were reviewed retrospectively. Statistical analyzes were performed using SPSS version 15.0 software. A total of 20 patients with metastatic colorectal cancer using regorafenib in the third or fourth line therapy were included in the study. Overall, 15 (75%) patients had liver metastases. The median overall survival of the patients was 25.5 months (95% Confidence Interval (CI), 24.1-26.8). Overall survival was not significantly associated with sex, ECOG performance status score, de novo metastatic disease status, smoking status and weight loss history (p=0.139, p=0.240, p=0.173, p=0.911, p=0.923, respectively). A significant association was found between the presence of liver metastasis and survival (p=0.036). The median overall survival was 40.3 months (95% CI, 0-92.6) in patients without liver metastases, and 25 months (95% CI: 13.8-36.2) in patients with liver metastases. In this retrospective study investigating the factors affecting the survival of patients using regorafenib with the diagnosis of mCRC, the presence of liver metastasis was found to be associated with a poor prognosis.
APA, Harvard, Vancouver, ISO, and other styles
8

Kutsal, Yeşim Gökçe. "The Frequency of the Clinical Risk Factors in Postmenopausal Osteoporosis." Turkish Journal of Rheumatology 28, no. 4 (December 13, 2013): 256–62. http://dx.doi.org/10.5606/tjr.2013.3336.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Walinjkar, Manjiri. "Clinical study to evaluate the causative factors of Shvitra (Vitiligo)." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 2, no. 5 (January 25, 2017): 130–34. http://dx.doi.org/10.21276/jrtm.2016/304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Guedes, Nirla Gomes, Marcos Venícios de Oliveira Lopes, Viviane Martins da Silva, Lara Jales Rodrigues Farias, Leonardo Alexandrino da Silva, and Cristina Costa Bessa. "Clinical validation of factors associated with sedentary lifestyle in adolescents." Rev Rene 20 (May 16, 2019): e40395. http://dx.doi.org/10.15253/2175-6783.20192040395.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Clinical factors"

1

Lee, Chung-won. "Non-Clinical Risk Factors of Hysterectomy." DigitalCommons@USU, 2001. https://digitalcommons.usu.edu/etd/4336.

Full text
Abstract:
In the United States, hysterectomy is one of the most commonly performed operations for women that is not related with pregnancy. However, not enough attention has been paid to how women's exposure to the surgery differs according to their social characteristics as well attitudinal/behavioral factors. Using cohort data from the National Longitudinal Surveys of Mature Women, this study investigated two aspects: (1) the association between socioeconomic status and hysterectomy and (2) the impact of women's attitudinal/behavioral characteristics on hysterectomy. With Cox proportional hazards analyses, this study found that women's exposure to hysterectomy significantly differs according to their social and attitudinal standings. Social characteristics that were found to be statistically significant risk factors of hysterectomy include women's eduction, employment status, and marital status. Among additional and behavioral factors, women's locus of control and number of children were identified as statistically significant risk factors. These findings may be used to enhance consumer awareness of hysterectomy and aid in policy reconstruction.
APA, Harvard, Vancouver, ISO, and other styles
2

Chronopoulos, Aristeidis. "Clinical presentation and risk factors of osteoradionecrosis." Diss., Ludwig-Maximilians-Universität München, 2015. http://nbn-resolving.de/urn:nbn:de:bvb:19-180892.

Full text
Abstract:
Introduction: Osteoradionecrosis (ORN) of the jaws is defined as exposed irradiated bone that fails to heal over a period of 3 months without the evidence of a persisting or recurrent tumor. In the previous decades, numerous factors were associated with the risk of ORN development and severity. Aims: The purposes of this study were to present the data of the patients that were treated for ORN in the Department of Oral and Maxillofacial Surgery in Munich (LMU), to detect factors that contributed to the onset of ORN, to identify risk factors associated with the severity of ORN and finally, to delineate and correlate these factors with the personal, health and treatment characteristics of the patients. Material and Methods: A retrospective study was conducted during the period from January 2003 until December 2012 that included all ORN cases having been treated in the Department of Oral and Maxillofacial Surgery in Munich (LMU). The total sample was categorized in three groups according to stage and several variables were evaluated in an attempt to identify possible correlations between them and the necrosis severity. Results: One hundred and fifty three cases of ORN were documented. Among them, 23 (15.1%) cases were stage I, 31 (20.2%) were stage II and 99 (64.7%) were stage III and all localised in the mandible. There was a predominance of the disease in the posterior region when compared to the anterior region. The majority of cases was addicted to alcohol and tobacco abuse and was suffering from Diabetes Mellitus (DM). All cases were treated with RT and 80.4% of them with concomitant chemotherapy. The initial tumor was predominantly located in the floor of the mouth, the tongue and the pharynx. Αpproximately two thirds of the cases occured either after dental treatment or due to a local pathological condition. Logistic regression analysis identified Diabetes Mellitus (OR: 4.955, 95% Cl: 1.965-12.495), active smoking (OR: 13.542, 95% Cl: 2.085-87.947), excessive alcohol consumption (OR: 5.428, 95% Cl: 1.622-18.171) and dental treatment/ local pathological condition (OR: 0.237, 95% Cl: 0.086-0.655) as significant predictors for stage III necrosis. Tumor size (T) (p<0.001), stage of the tumor (UICC) (p=0.001), concomitant chemotherapy (p<0.001), dental examination and treatment prior to RT (p<0.001) and the different causes of ORN (p=0.03) were statistically significantly associated with the severity of ORN. Conclusion: The aforementioned factors are predictive of ORN severity and can guide its prophylaxis and management. Based on these findings, prospective studies should be conducted in order to better understand risk factors associated with the development, severity and pathophysiology of ORN and improve treatment strategies for this complication of RT.
APA, Harvard, Vancouver, ISO, and other styles
3

Newrick, P. G. "Clinical and vascular factors in diabetic neuropathy." Thesis, University of Bristol, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.381409.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Penkal, Jessica Lynn. "Factors Associated with Stalking Victimization." University of Dayton / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=dayton1375232327.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gunnard, Katarina. "Risk factors and clinical correlates in eating disorders." Doctoral thesis, Universitat de Barcelona, 2012. http://hdl.handle.net/10803/81472.

Full text
Abstract:
The central scientific objective of the current dissertation was to take a multidisciplinary approach to make use of the full potential information, both scientific and clinical to aid prevention and treatment of EDs. In our studies we assessed a.) social and individual risk factors in EDs (Study 1), b.) empirical ED subtypes based on drive for thinness (DT) and depression (Study 2) and c.) the classification based on these four different empirical ED subtypes without cluster analysis and based on the use of clinical cutoff scores of DT and depression. Finally, we assessed the predictive validity for this subtyping scheme with regard to dropout from CBT in an unselected BN-P population seeking treatment. Our first line of investigation (Study 1) assessed social and self-standards in EDs. The results of the study suggest that compared to healthy controls, standards for physical appearance, family standards and self-achievements were higher in individuals with EDs, that ED patients show higher self-discrepancy between their personal and social values and confidence to attain them and that the conflict with their significant others over these issues was higher. Furthermore, high social and self-standards was associated with developing an ED, which emphasize the importance of assessing risk factors in ED. Finally we also observed differences in the ED subtypes; physical appearance a greater risk factor in BN and EDNOS while social-other standards were more associated with AN. The second research area (Study 2 and 3) explored new empirical ED subtypes along DT and depression. In our initial study (Study 2) we found four new ED subtypes through cluster analysis; “DT”, “DT-Depressive”, “mild DT” and “depressive-moderate DT”. This result indicates that dieting and depression are useful for analyzing and identifying ED subtypes. Study 3 further assessed these empirical subtypes and found that the same subtypes emerged when basing them on scores from clinical well-validated questionnaires and moreover that attrition rates differed between subtypes and that the dropout rate was highest for the “DT-Depressive” subtype. Our findings agree with the growing body of research indicating the importance of dieting and comorbid depression as contributing factors in ED diagnoses. Finally, these findings will hopefully aid in resolving the current controversy surrounding current DSM-ED classifications.
El objetivo central de esta tesis ha sido, desde una perspectiva multidisciplinar, integrar los conocimientos clínicos y científicos para contribuir en el avance de la prevención y tratamiento de los Trastornos de la Conducta Alimentaria (TCA). En estos estudios, se han explorado una serie de aspectos como a) factores de riesgo sociales e individuales en los TCA (estudio 1), b) identificación de subtipos empíricos de los TCA, basados en el impulso a la delgadez y la realización de dietas y la depresión (estudio 2), y c) asociación entre los cuatro subtipos de TCA, basados en los factores descritos, y respuesta a un abordaje cognitivo-conductual, en una población con diagnóstico de bulimia nerviosa purgativa (BN-P), que solicitaron tratamiento por su trastorno (estudio 3). Nuestra primera línea de investigación (estudio 1) analizó la implicación de las expectativas sociales e individuales en los TCA. Los resultados de este trabajo sugirieron que las expectativas familiares, individuales y las relacionadas con la apariencia física, eran superiores en pacientes con TCA que en sujetos control. Asimismo, los pacientes con diagnóstico de TCA mostraban mayor discrepancia entre sus valores personales y sociales, menor confianza en poder alcanzarlos y mayor conflicto con sus familiares por estas cuestiones. Por otra parte, la presencia de elevadas expectativas sociales y personales se asociaba al desarrollo de un TCA, lo que enfatizaba la importancia de evaluar estos factores de riesgo. Finalmente, se observaron diferencias significativas entre los subtipos de TCA, siendo la apariencia física un factor de riesgo más presente en BN y en trastornos de la conducta alimentaria no especificados (TCANE), mientras que otras expectativas sociales se asociaban más a la anorexia nerviosa (AN). La segunda línea de investigación (estudios 2 y 3) exploraba nuevos subtipos empíricos de TCA, teniendo en cuenta las variables de impulso a la delgadez y realización de dietas (ID) y la depresión (D). En el primer trabajo (estudio 2), se obtuvieron cuatro nuevos subtipos a través de un análisis de cluster. Los subgrupos fueron “ID”, “IDDepresivo”, “ID moderado” y “D-ID moderado”. Estos resultados mostraban que la realización de dietas y la depresión eran útiles en el análisis e identificación de subtipos en los TCA. En el estudio 3 se exploraban estos subtipos con mayor profundidad, observando que se obtenían los mismos subgrupos, cuando nos basábamos en las puntuaciones de diversos cuestionarios clínicos validados. Asimismo, la respuesta al tratamiento era distinta en función de los subtipos de TCA, presentando tasas de abandonos más elevadas el subtipo “ID-Depresivo”. De este modo, los resultados estaban en concordancia con las evidencias empíricas, cada vez mayores, que indican la importancia de la realización de dietas y la depresión comórbida como factores que contribuyen a explicar características diagnósticas en los TCA. Finalmente, estos hallazgos podrían tener una relevancia destacada en la controversia actual sobre las clasificaciones diagnósticas en el próximo DSM.
L’objectiu central d’aquesta tesi ha estat, des d’una perspectiva multidisciplinar, integrar els coneixements clínics i científics per a contribuir a l’avenç de la prevenció i tractament dels trastorns de la conducta alimentària (TCA). En aquests estudis, s’han explorat una sèrie d’aspectes com a) factors de risc socials i individuals en els TCA (estudi 1), b) identificació de subtipus empírics dels TCA, i c) associació entre els quatre subtipus de TCA, basats en els factors descrits, i resposta a un abordatge cognitivoconductual, en una població amb diagnòstic de bulímia nerviosa purgativa (BN-P), que varen sol•licitar tractament pel seu trastorn (estudi 3). La nostra primera línia de recerca (estudi 1) va analitzar la implicació de les expectatives socials i individuals en els TCA. Els resultats d’aquest treball varen suggerir que les expectatives familiars, individuals i les relacionades amb l’aparença física, eren superiors en pacients amb TCA que en subjectes control. Alhora, els pacients amb diagnòstic de TCA mostraven major discrepància entre els seus valors personals i socials, menor confiança en poder aconseguir-los i major conflicte amb els seus familiars per aquestes qüestions. Per altra banda, la presència d’elevades expectatives socials i personals s’associava al desenvolupament d’un TCA, fet que emfatitzava la importància d’avaluar aquests factors de risc. Finalment, es varen observar diferències significatives entre els subtipus de TCA, sent l’aparença física un factor de risc més present en BN i en trastorns de la conducta alimentària no especificats (TCANE), mentre que altres expectatives socials s’associaven més a l’anorèxia nerviosa (AN). La segona línia de recerca (estudis 2 i 3) explorava nous subtipus empírics de TCA, tenint en compte les variables d’impuls a estar prim i realització de dietes (ID) i la depressió (D). En el primer treball (estudi 2), es varen obtenir quatre nous subtipus a través d’una anàlisi de cluster. Els subgrups foren “ID”, “ID-Depressiu”,“ID moderat” i “D-ID moderat”. Aquests resultants mostraven que la realització de dietes i la depressió eren útils en l’anàlisi i identificació de subtipus en els TCA. En l’estudi 3 s’exploraven aquests subtipus amb major profunditat, observant que s’obtenien els mateixos subgrups, quan ens basàvem en les puntuacions de diversos qüestionaris clínics validats. Alhora, la resposta al tractament era diferent en funció dels subtipus de TCA, presentant taxes d’abandonament més elevades el subtipus “IDDepressiu”. D’aquesta manera, els resultats estaven en concordança amb les evidències empíriques, cada vegada més grans, que indiquen la importància de la realització de dietes i la depressió comòrbida, com a factors que contribueixen a explicar les característiques diagnòstiques en els TCA. Finalment, aquestes troballes podrien tenir una rellevància destacada en la controvèrsia actual sobre les classificacions diagnòstiques en el proper DSM.
APA, Harvard, Vancouver, ISO, and other styles
6

Diederen, Roselie Maria Helena. "Biochemical and clinical factors in rhegmatogenous retinal detachment." [Maastricht : Maastricht : Universiteit Maastricht] ; University Library, Universiteit Maastricht [host], 2007. http://arno.unimaas.nl/show.cgi?fid=8304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Asch, Rachel E. "Factors influencing participation in screening and clinical trials." Thesis, Cranfield University, 1988. http://dspace.lib.cranfield.ac.uk/handle/1826/4790.

Full text
Abstract:
The reported research was an investigation of attitudes and beliefs associated with participation in screening programmes and clinical trials, carried out by general practitioners. Particular focus was given to cardiovascular risk-reduction. The work comprised two main studies. The preliminary study was entirely exploratory, designed to guage public attitudes towards GP involvement with preventive screening programmes and clinical research; and to identify the range of variables associated with participation in such projects. The subsequent study utilised a more formal approach in which the Behavioural Intention Model was utilised to evaluate the power of influencing factors. Both studies employed self-completion questionnaires, developed from preliminary in-depth interview data. For the first study instrument distribution was effected by personal approach, for the second study postal distribution was employed. In all, 1,037 respondents contributed to the surveys - 442 to the preliminary exploration and 695 to the follow-on study. These represented response rates of approximately 65% and 36% respectively. The main findings were that attitudes towards screening were generally favourable, though there was less conformity in attitudes expressed towards clinical trials. These findings were reflected in reported participatory intentions. No evidence was found of any factors which might pose widespread barr i ers to screen ing part ic i pa t ion, though some potent ia 1 deterren ts were identified for older women. It was also noted that other potential deterrents may have been masked by the 'middle class' bias of the sample. Major deterrents to trial entry were identified as worries about: sideeffects, acquired resistance, discontinuation of current effective medications and lack of adequate information. These all interacted with the 'guinea pig' factor. Response rates and responses associated with medical and non-medical sampling sources were also discussed; and consideration was made of the general utility of the Behavioural Intention Model for research of this kind.
APA, Harvard, Vancouver, ISO, and other styles
8

Hussey, David Llewellyn. "Factors affecting clinical performance of resin bonded bridgework." Thesis, Queen's University Belfast, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.322950.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Robinson, C. J. E. "Factors associated with self-compassion in clinical psychologists." Thesis, University of Essex, 2015. http://repository.essex.ac.uk/15221/.

Full text
Abstract:
At present, two dominant conceptualisations of self-compassion exist. However, a unifying consensus includes self-compassion as a basic kindness and an understanding, non-judgemental attitude towards ones inadequacies and failures (Neff, 2003a), coupled with the wish and effort to relieve ones suffering (Gilbert, 2010a). A review of the literature reveals elevated stress levels within clinical psychologists (CP’s) and a disproportionate amount of research exploring effective self-care strategies. Given the well-evidenced benefits of self-compassion for good psychological wellbeing, it seemed valuable to understand what the levels of self-compassion were within CP’s and establish what factors may relate to them. The factors explored in the present research were: 1) current levels of stress, 2) current level of psychological distress, 3) age of clinician, 4) years of clinical experience, 5) level of social connectedness, 6) fear of giving compassion to others, 7) fear of receiving compassion from others and 8) fear of self-compassion. Furthermore, no research had demonstrated UK community normative data for the Self-Compassion Scale (Neff, 2003b). Therefore this research adopted a quantitative, cross sectional design, using both online and paper methods to access a community sample and an online survey to access trainee and qualified CP’s. Analyses revealed that qualified CP’s reported significantly higher self-compassion than trainees, themselves significantly higher than a community sample. A multiple regression analyses revealed that fear of self-compassion, perceived stress and social connectedness, significantly related to self-compassion scores in trainee CP’s. Within the qualified CP, fear of self-compassion and perceived stress again were found to significantly relate to self-compassion. Results also demonstrated that in the UK, 1/3rd of trainee CP’s and 1/5th of qualified CP’s reported psychological distress significant enough to meet the clinical criteria for an anxiety or depressive disorder. These findings are therefore discussed and clinical implications are presented.
APA, Harvard, Vancouver, ISO, and other styles
10

Hancock, Eleanor. "Tuberous sclerosis : clinical factors in long term outcome." Thesis, University of Bath, 2003. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269678.

Full text
Abstract:
Tuberous sclerosis (TSC) is a dominantly inherited disorder with a high spontaneous mutation rate and a birth incidence of 1 in 10,000. It is a systemic disorder characterised by the growth of hamartomas, which in turn give rise to the clinical manifestations, for example, epilepsy and learning difficulties. Although some patients with TSC are only mildly affected and lead a normal life with typical life expectancy, there is an immense amount of morbidity associated with this disease. In addition, for the majority of patients there is reduced life expectancy. The purpose of this thesis is to look at the clinical factors that contribute to the morbidity and mortality seen in TSC and examine means of reducing the impact of these factors on long-term outcome. It reports a longitudinal population study of a small but defined group of patients looking at the epidemiology and natural history (the morbidity and mortality) suffered by in this population. It investigates the current treatment regimes for the types of epilepsy (infantile spasms and nonconvulsive status epilepticus) known to be associated with the highest risk of learning difficulties in order to determine the most efficacious treatment for the seizures potentially reducing long-term psychomotor delay. A cochrane review of the treatment of infantile spasms was performed. This thesis also examines the effect of exogenous melatonin on sleep disorders (one of the major causes of morbidity) in tuberous sclerosis and the natural circadian rhythms in patients with sleep disorder in TSC and compares them with the normal population. Two important causes of premature mortality in TSC patients are respiratory and renal failure. This thesis examines the prevalence and underlying causes of end stage renal failure in adults with TSC and reviews the literature of LAM (in patients both with and without TSC) investigating further the natural history and treatment of LAM in TSC.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Clinical factors"

1

Van de Water, Thomas R. and Koszer Samuel, eds. Clinical applications of neurotrophic factors. Philadelphia: Lippincott-Raven, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Washburn, Sandra Jean. Sustaining factors in clinical depression. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gregory, Bock, Marsh Joan, and Symposium on Clinical Applications of TGF-[beta] (1990 : Ciba Foundation), eds. Clinical applications of TGF-[beta]. Chichester: Wiley, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schenck-Gustafsson, Karin. Handbook of clinical gender medicine. Basel: Karger, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Handbook of clinical gender medicine. Basel: Karger, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Roland, Mertelsmann, and Herrmann Friedhelm 1949-, eds. Hematopoietic growth factors in clinical applications. 2nd ed. New York: M. Dekker, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Roland, Mertelsmann, and Herrmann Friedhelm 1949-, eds. Hematopoietic growth factors in clinical applications. New York: Dekker, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lal, Adhya Sankar, ed. RNA polymerase and associated factors. San Diego, Calif: Academic Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

1950-, Nicola Nicos, ed. The hemopoietic colony-stimulating factors: From biology to clinical applications. Cambridge: Cambridge University Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

R, Sara Vicki, Hall Kerstin, Löw Hans, Karolinska institutet, and Nobel Conference (Karolinska institutet) (17th : 1989 : Stockholm, Sweden), eds. Growth factors: From genes to clinical application. New York: Raven Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Clinical factors"

1

Oster, W., F. Herrmann, A. Lindemann, and R. Mertelsmann. "Experimental and Clinical Evaluation of Erythropoietin." In Growth Factors, Differentiation Factors, and Cytokines, 232–42. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74856-1_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Heilbronner, Robert L. "Aggravating Factors." In Encyclopedia of Clinical Neuropsychology, 73–74. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_942.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Heilbronner, Robert L. "Mitigating Factors." In Encyclopedia of Clinical Neuropsychology, 1639–40. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_1011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Heilbronner, Robert L. "Mitigating Factors." In Encyclopedia of Clinical Neuropsychology, 1–2. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56782-2_1011-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Heilbronner, Robert L. "Aggravating Factors." In Encyclopedia of Clinical Neuropsychology, 1–2. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56782-2_942-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Heilbronner, Robert L. "Mitigating Factors." In Encyclopedia of Clinical Neuropsychology, 2245–46. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_1011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chen, K., and S. P. Finklestein. "Neurotrophic Factors." In Monographs in Clinical Neuroscience, 116–27. Basel: KARGER, 1997. http://dx.doi.org/10.1159/000061574.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Heilbronner, Robert L. "Aggravating Factors." In Encyclopedia of Clinical Neuropsychology, 50–51. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_942.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Du Caju, M. V. L. "Growth Factors in Malnutrition." In Clinical Chemistry, 557–60. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0753-2_56.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schweigerer, L. "Basic Fibroblast Growth Factor: Properties and Clinical Implications." In Growth Factors, Differentiation Factors, and Cytokines, 42–55. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74856-1_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Clinical factors"

1

Inzerillo, Sean, Julia Weiner, Wei Tang, Leila Khalili, Julia Barasch, Peter Izmirly, Shira Kaplan, et al. "609 Demographic and clinical factors that contribute to clinical study enrollment." In LUPUS 21ST CENTURY 2022 CONFERENCE, Abstracts of Sixth Scientific Meeting of North American and European Lupus Community, Tucson, AZ, USA – September 20–23, 2022. Lupus Foundation of America, 2022. http://dx.doi.org/10.1136/lupus-2022-lupus21century.30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gonchar, M. O., Ye V. Ivanova, V. S. Tokariev, I. R. Kolesnikov, and H. O. Pizniak. "Neonatal arrhythmia: development risk factors." In NEW TRENDS AND UNRESOLVED ISSUES OF PREVENTIVE AND CLINICAL MEDICINE. Baltija Publishing, 2020. http://dx.doi.org/10.30525/978-9934-588-81-5-1.19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Han, Jiyeon, Jimin Park, Jinyoung Huh, Uran Oh, Jaeyoung Do, and Daehee Kim. "AscleAI: A LLM-based Clinical Note Management System for Enhancing Clinician Productivity." In CHI '24: CHI Conference on Human Factors in Computing Systems. New York, NY, USA: ACM, 2024. http://dx.doi.org/10.1145/3613905.3650784.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zhou, Xiaomu. "Session details: Papers: clinical settings." In CHI '13: CHI Conference on Human Factors in Computing Systems. New York, NY, USA: ACM, 2013. http://dx.doi.org/10.1145/3250081.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Philipps, Jonathan, and Kai Heinrich. "Influencing Factors of Clinical Patient Recruitment Systems Design." In Hawaii International Conference on System Sciences. Hawaii International Conference on System Sciences, 2019. http://dx.doi.org/10.24251/hicss.2019.493.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Esmer, Bilgen, Tijen Sengezer, Funda Aksu, Adem Özkara, and Kurtulus Aksu. "Clinical and demographical factors influencing smoking cessation rates." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa1181.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mejri Ep Ajili, Islam, Soumaya Ben Saad, Achref Ben Tkhayet, Hafaoua Daghfous, and Fatma Tritar. "Risk factors of severe clinical forms of tuberculosis." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2662.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fu, Kexin. "Transdiagnostic Factors Across Eating Disorders: A Clinical Review." In 2021 2nd International Conference on Mental Health and Humanities Education(ICMHHE 2021). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/assehr.k.210617.111.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rule, Adam, Isaac H. Goldstein, Michael F. Chiang, and Michelle R. Hribar. "Clinical Documentation as End-User Programming." In CHI '20: CHI Conference on Human Factors in Computing Systems. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3313831.3376205.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zachary, Wayne, and Russell Maulitz. "Cognitive Interaction Analysis of Clinical Encounters." In 2012 Symposium on Human Factors and Ergonomics in Health Care. Human Factors and Ergonomics Society, 2012. http://dx.doi.org/10.1518/hcs-2012.945289401.019.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Clinical factors"

1

Manosroi, Worapaka, Pichitchai Atthakomol, Piti Inthaphan, and phichayut Phinyo. Predictive factors of clinical cure after adrenalectomy in primary aldosteronism. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bouranis, Nicole. Factors Affecting Clinical Research Enrollment Among Individuals with Alzheimer's Disease and Related Dementias. Portland State University Library, June 2020. http://dx.doi.org/10.15760/etd.7337.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Liu, Qianqiu, Guanhua Jiang, Jing Ning, and Yongqin Zhang. Meta analysis on Influencing Factors of evidence-based nursing ability of clinical nurses. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2021. http://dx.doi.org/10.37766/inplasy2021.3.0007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bernabeu-Mira, Juan Carlos, David Soto-Peñaloza, David Peñarrocha-Oltra, and Miguel Peñarrocha-Diago. In vitro, pre-clinical, and clinical factors of low-speed drilling without irrigation of the implant bed compared to the conventional drilling: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2020. http://dx.doi.org/10.37766/inplasy2020.11.0138.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Richter-Levin, Gal. Early Life Stress and Sleep Restriction as Risk Factors in PTSD: An Integrative Pre-Clinical Approach. Fort Belvoir, VA: Defense Technical Information Center, April 2012. http://dx.doi.org/10.21236/ada567825.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lowry, Sventlana Z., Mala Ramaiah, Emily S. Patterson, David Brick, Ayse P. Gurses, Ant Ozok, Debora Simmons, and Michael C. Gibbons. Integrating electronic health records into clinical workflow : an application of human factors modeling methods to ambulatory care. National Institute of Standards and Technology, March 2014. http://dx.doi.org/10.6028/nist.ir.7988.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Glista, Danielle, Robin O’Hagan, Danielle DiFabio, Sheila Moodie, Karen Muñoz, Keiran Joseph, Christine Brown, et al. Virtual Hearing Aid Care – Clinical Practice Guidance Document. Western Libraries, Western University, August 2021. http://dx.doi.org/10.5206/0820211097.

Full text
Abstract:
This document was informed by literature reviews conducted in accordance with the Joanna Briggs Institute’s guide to evidence synthesis (Aromataris & Munn, 2017; https://joannabriggs.org) and includes evidence related to client candidacy, delivery models, modalities of delivery, and outcomes of virtual hearing aid fitting and management. This document provides clinical practice guidance for virtual hearing aid fitting and management processes and technological requirements in the delivery of such services (herein referred to as virtual hearing aid care). Virtual hearing aid care can include services delivered directly to a client by a provider or using facilitator-supported services and specialized equipment, depending on client factors, type of care, and the timepoint in the care process (e.g., initial versus follow-up appointments). This document will address virtual care including the following types of hearing aid care: o Programming o Verification o Validation o Management (counselling and education) Currently, virtual hearing aid care is better suited to follow-up appointments
APA, Harvard, Vancouver, ISO, and other styles
8

Gathu, Michael. What are the effects of interventions to encourage the use of systematic reviews in clinical decision making? SUPPORT, 2017. http://dx.doi.org/10.30846/170111.

Full text
Abstract:
Clinical decision making is often not based on the best available evidence. Reasons for this vary, and may be related to factors within the healthcare setting, patients, or health practitioners. Interventions have been designed to encourage the use of systematic reviews in making clinical decisions as one way of improving clinical decision making.
APA, Harvard, Vancouver, ISO, and other styles
9

Fang, Pengzhong, Yamin Chen, Jinlei Chen, Junhao Sun, Jianshi Tan, Ruirui Wang, and Xing Wang. What Factors Affect the Methodological and Reporting Quality of Clinical Practice Guidelines for Osteoporosis? Protocol for A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2020. http://dx.doi.org/10.37766/inplasy2020.7.0031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Yu, Mingkun, Changhao Liang, Qian He, Kexin Liu, Yuting Feng, Qianyun Chai, Jianping Liu, and Yutong Fei. The Process factors and improvement strategies of patient compliance and retention in clinical trials: a synthesis of qualitative research. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2021. http://dx.doi.org/10.37766/inplasy2021.2.0024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography